Fraboc, usually written FRA-BOC, stands for Familial Risk Assessment – Breast and Ovarian Cancer. It was an online tool that helped healthcare professionals assess cancer risk using family history. Cancer Australia confirms that the original tool is no longer available on its website and that newer breast cancer risk-assessment tools are available.
Quick Facts About Fraboc
| Question | Answer |
|---|---|
| Established name | Familial Risk Assessment – Breast and Ovarian Cancer |
| Common spelling | FRA-BOC or FRABOC |
| Main purpose | Assessing risk associated with family history |
| Intended users | Healthcare professionals |
| Medical context | Breast and ovarian cancer |
| Current availability | No longer available through Cancer Australia |
| Is it a diagnosis? | No |
| Is it a genetic test? | No |
| Current breast-risk resource | iPrevent is one available option |
| Best use of an old result | Discuss it with a healthcare professional using current guidance |
Understanding the Name
“Familial” means related to a family. In healthcare, family history can help identify patterns that deserve closer attention.
For example, a clinician may want to know which relatives had cancer, what type they had, and how old they were when diagnosed. These details can be more useful than a simple statement that “cancer runs in the family.”
FRA-BOC organized this kind of information to support clinical assessment. Historical Cancer Australia guidance directed health professionals to the tool for family-history situations beyond those covered by its printed tables.
Its purpose was to support a conversation about risk and possible next steps. It did not examine a person’s body or test a sample in a laboratory.
Why Family History Matters
Family members can share inherited gene changes, environments, and habits. These can all contribute to patterns of illness within a family.
A family history of certain cancers may therefore affect a person’s risk. However, it does not establish that every cancer in the family has the same cause.
This distinction is reassuring without dismissing genuine concerns. A relative’s diagnosis is useful medical information, but it is not a prediction of another family member’s future.
A clinician considers the overall pattern. One isolated diagnosis and several related cancers occurring at young ages may lead to different assessments.
What Information Is Useful?
When preparing to discuss family cancer history, the following details can help:
- Which blood relative had cancer.
- The type of cancer diagnosed.
- Their age at diagnosis, if known.
- Whether they had more than one cancer.
- Whether a harmful inherited gene change has been identified in the family.
Patterns such as breast cancer at a young age, ovarian cancer, male breast cancer, or several relatives with related cancers may prompt closer assessment. They are reasons for discussion, not proof of an inherited condition.
You do not need to arrive with a perfect family record. Write down what you know and mark uncertain details as uncertain.
For example, “an aunt had cancer, but I do not know which kind” is more useful than guessing. A healthcare professional can explain whether finding out more would change the assessment.
Both Sides of the Family Count
Breast and ovarian cancer history is sometimes discussed only through mothers, sisters, and maternal grandmothers. The father’s side matters too.
CDC guidance emphasizes collecting information from both maternal and paternal relatives when assessing hereditary cancer risk. A relevant inherited change can come through either parent.
This means a paternal aunt’s or grandmother’s diagnosis should not be left out simply because it is on the father’s side.
Family history is about biological connections across generations. It is not limited to relatives who have the same sex as the person being assessed.
A Risk Assessment Is Different From a Diagnosis
A risk assessment estimates likelihood. A diagnosis determines whether someone has a disease.
That difference is easy to lose when an assessment produces a category or percentage. A higher-risk result can sound like a diagnosis, even though it is describing a possibility.
BreastScreen SA explains that some people classified as being at increased risk never develop breast cancer, while some people at lower risk do. Risk tools cannot guarantee an individual outcome.
Consider a made-up example: a risk estimate of 10% over a stated period describes what may happen across a group of people with similar characteristics. It cannot identify exactly which individuals will develop the condition.
The time period also matters. A ten-year estimate and a lifetime estimate answer different questions and should not be compared as though they mean the same thing.
Was Fraboc a Genetic Test?
No. FRA-BOC used family information to support risk assessment.
Genetic testing examines a biological sample for particular gene changes. Testing for inherited cancer risk often uses blood or saliva and may look at several genes together.
These activities can be connected, but they are separate steps. A family-history assessment may help a clinician decide whether genetic counseling or testing could be useful.
An online questionnaire cannot establish that someone carries a specific inherited gene change. That requires appropriate testing and interpretation.
Where BRCA1 and BRCA2 Fit In
BRCA1 and BRCA2 are genes associated with hereditary cancer risk when certain harmful changes are present.
The National Cancer Institute explains that inherited harmful changes in these genes can substantially increase breast and ovarian cancer risk. Having such a change still does not mean that cancer is certain to develop.
It is also important to distinguish inheriting a risk-related gene change from inheriting cancer itself. Cancer is not passed directly from parent to child; an inherited change can increase susceptibility.
BRCA1 and BRCA2 are not the only genes relevant to hereditary cancer. A genetics professional can help determine which testing approach, if any, fits the person’s history.
Is Fraboc Still Available?
Cancer Australia states that FRA-BOC is no longer available on its website.
Older documents may still mention it because they were written when the tool was in use. Finding the name in an old leaflet does not mean that the tool remains the current option.
An old result can still provide background for a medical conversation. However, the next step should be based on current information, including any changes in personal or family history.
There is no need to recreate a score using an unofficial copy of an old questionnaire.
What Is Used Today?
One current option is iPrevent, a breast cancer risk-assessment and decision-support tool associated with Peter MacCallum Cancer Centre.
It is designed to support discussions about prevention and screening. Its stated focus is breast cancer, so it should not be described as a direct replacement for every breast-and-ovarian function associated with FRA-BOC.
BreastScreen SA describes iPrevent as suitable for women who have not had invasive breast cancer or ductal carcinoma in situ, also called DCIS. It produces a downloadable report and takes around 30 minutes to complete.
Other tools exist, and they do not all use identical information or serve the same purpose. A healthcare professional can select an appropriate assessment rather than assuming every calculator is interchangeable.
What Happens During Genetic Counseling?
Genetic counseling helps people understand whether testing could be useful and what different results might mean.
The discussion may cover the family’s cancer history, the benefits and limits of testing, possible effects on relatives, and emotional concerns. Counseling is generally recommended before testing for inherited cancer risk.
It is an opportunity to ask questions, rather than a commitment to undergo a test.
CDC guidance also notes that, when possible, testing may begin with a family member who has had a relevant cancer. That can help make the results more informative for the wider family.
The right starting point depends on the circumstances. Different families may need different approaches.
Does a Negative Genetic Test Remove All Risk?
A negative result does not automatically mean there is no cancer risk.
Its meaning depends partly on whether a specific harmful change has already been identified in the family. If no familial change is known, a negative result may leave important questions unanswered.
Personal and family history can remain relevant even after testing. This is one reason results should be explained by someone who understands the clinical context.
A result is most useful when it becomes part of an appropriate care plan, rather than being treated as a stand-alone answer.
Preparing for a Conversation With Your Doctor
If you encounter “Fraboc” in an old record, bring the document to your appointment.
You could ask:
- What did this assessment mean at the time?
- Has our family history changed since then?
- Would a current risk assessment be useful?
- Is genetic counseling appropriate?
- What follow-up applies to me now?
Collecting family information beforehand can make the discussion easier. CDC encourages people to learn their family cancer history and share it with their doctor.
Keep the conversation practical. The goal is to understand what information matters and what action, if any, is appropriate.
Do Not Use a Risk Score to Explain Away Symptoms
A risk calculator is not a way to assess a new breast change.
Cancer Australia advises seeing a doctor without delay for an unusual change, such as a new lump, nipple change, discharge, or skin dimpling. This applies even when someone has previously received a reassuring risk assessment.
Risk assessment and symptom assessment address different questions. One looks at likelihood; the other investigates something happening now.
This article explains the term and its context. It does not calculate an individual’s cancer risk.
Why Some Websites Describe Fraboc Differently
Search results also contain articles calling Fraboc a business method, productivity framework, or digital system.
I did not find authoritative documentation establishing those descriptions as a recognized method, or showing that the medical tool evolved into such a framework.
The medical meaning has a clear source in Cancer Australia’s own materials. Other uses should be checked in their specific context rather than combined into a single origin story.
That matters because an unfamiliar word can attract confident explanations that are difficult to verify. A clear definition should come before claims about popularity, innovation, or benefits.
Final Thoughts
Fraboc refers most clearly to FRA-BOC, a former tool for assessing familial breast and ovarian cancer risk. Its continuing value for readers is understanding why family history matters and why risk assessment is different from diagnosis.
The original tool is no longer available through Cancer Australia. Anyone with an old result or concerns about family history can use that information to begin a current discussion with a healthcare professional.
Frequently Asked Questions
What does Fraboc stand for?
Familial Risk Assessment – Breast and Ovarian Cancer.
Was Fraboc a cancer test?
It was a family-history risk-assessment tool, not a diagnostic or laboratory test.
Can I still use the original FRA-BOC tool?
Cancer Australia says it is no longer available on its website.
What is one current alternative for breast cancer risk assessment?
iPrevent is an available tool designed to support prevention and screening discussions.
Does my father’s family history matter?
Yes. Relevant history on both sides of the family should be included.
Does a higher-risk result mean I will develop cancer?
No. A risk estimate describes likelihood, not certainty.
Should everyone with a relative who had cancer get genetic testing?
Not automatically. A clinician or genetic counselor can assess whether testing would be useful.
For more info, visit Picanto Magazine.